Results 71 to 80 of about 7,418 (172)

Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis

open access: yesHuman Vaccines & Immunotherapeutics, 2020
The leishmaniases are a collection of vector-borne parasitic diseases caused by a number of different Leishmania species that are distributed worldwide.
Beatriz Coutinho De Oliveira   +2 more
doaj   +1 more source

Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations

open access: yesHealth Science Reports
Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies ...
Bahareh Abtahi‐Naeini   +5 more
doaj   +1 more source

Experimental cutaneous leishmaniasis: transmission electron microscopy of the inoculation site

open access: yesInternational Journal of Experimental Pathology, 1997
Tissue response against inoculation of Leishmania (Leishmania) amazonensis promastigotes in the hind footpad was quite different between two strains of mice: in BALB/c animals there was parasitism of perineurial cells by the 8th week post inoculation (WPI) and heavy parasitism of macrophages, as well as degenerated extracellular parasites close to ...
C, Vasconcellos, M N, Sotto
openaire   +3 more sources

Immunity and immunosuppression in experimental visceral leishmaniasis

open access: yesBrazilian Journal of Medical and Biological Research, 2004
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj  

Altered miRNA expression in the lesions of cutaneous leishmaniasis caused by L. major and L. tropica with insights into apoptosis regulation

open access: yesScientific Reports
Leishmaniasis is a vector-borne infectious disease that affects many subtropical countries. Leishmania (L.) major and L. tropica are among the old-world causative agents and cause cutaneous leishmaniasis (CL).
Taha Masoudsinaki   +11 more
doaj   +1 more source

MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis. [PDF]

open access: yesMicroorganisms, 2021
Oliveira-Maciel D   +10 more
europepmc   +1 more source

Drug-containing hydrophobic dressings as a topical experimental therapy for cutaneous leishmaniasis

open access: yesJournal of Parasitic Diseases, 2019
Cutaneous leishmaniasis (CL), a clinical condition caused mainly by Leishmania amazonensis in Brazil, is characterized by topical, painless ulcers. The current treatment, based on intravenous administration of pentavalent antimonials, presents low adherence by patients and may cause serious adverse effects, leading to the need for searching new ...
Viviane Pereira   +5 more
openaire   +3 more sources

Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis

open access: yesFrontiers in Immunology
Leishmaniasis is a complex disease caused by protozoan parasites of the genus Leishmania, which are transmitted by phlebotomine sand flies. The clinical manifestations of leishmaniasis are diverse, ranging from self-healing cutaneous lesions to fatal ...
Mahmoud Nateghi-Rostami   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy